Repaglinide Prescribing at BOSVENA HEALTH
Drugs used in diabetes | Endocrine System
Items (12m)
30
Total Quantity
4,938
NHS Cost
£173
vs National Avg
+24.1%
BOSVENA HEALTH prescribed 30 items of Repaglinide over the last 12 months at a cost of £173 to the NHS. This is 24.1% above the national average prescribing rate. Repaglinide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 30 |
|---|---|
| Total Quantity | 4,938 |
| Total NHS Cost | £173 |
| Presentations | 2 different forms |
| vs National Average | +24.1% |
Repaglinide Prescribing Comparison
| This practice | 30 items |
|---|---|
| National average per practice | 24 items |
| Difference | +24.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.